PE-conjugated Anti-IL13(lebrikizumab biosimilar) mAb

Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Description: PE-conjugated Anti-IL13(lebrikizumab biosimilar) mAb

Storage & Shipping: Store at 2°C-8°C fo 6 months

Formulation & Reconstitution: Liquid，PBS with 0.05% Proclin300, 574% BSA

Target: IL13

Uniprot ID: P35225

Usage: Research use only

Recommended Dilutions: Flow Cyt 1:100

Common Name: DRM 06DRM-06DRM06DRM 6DRM-6DRM6LY 3650150LY-3650150LY3650150MILR1444AMILR-1444AMILR 1444ARG 3637ARG-3637ARG3637RO 5490255RO-5490255RO5490255TNX 650TNX-650TXN650

Guarantee: 6 months from date of dispatch

• Artikelnummer: DMABME100548P-100
• Hersteller: DIMA Biotechnology
• Hersteller Artikelnummer: BME100548P-100
• Verpackungseinheit: 100 test
• Mengeneinheit: STK
• Reaktivität: Human
• Methode: Flow Cytometry
• Isotyp: IgG4
• Konjugat: Conjugated, PE (Phycoerythrin)